Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Short-term Investments (2016 - 2021)

Historic Short-term Investments for CV Sciences (CVSI) over the last 6 years, with Q2 2021 value amounting to $501000.0.

  • CV Sciences' Short-term Investments changed 0.0% to $501000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $501000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $501000.0 for FY2020, which is 0.0% changed from last year.
  • Per CV Sciences' latest filing, its Short-term Investments stood at $501000.0 for Q2 2021, which was down 0.0% from $501000.0 recorded in Q1 2021.
  • In the past 5 years, CV Sciences' Short-term Investments ranged from a high of $1.1 million in Q1 2017 and a low of $251000.0 during Q4 2018
  • In the last 5 years, CV Sciences' Short-term Investments had a median value of $501000.0 in 2019 and averaged $626045.7.
  • As far as peak fluctuations go, CV Sciences' Short-term Investments skyrocketed by 18249.2% in 2017, and later tumbled by 6776.18% in 2018.
  • CV Sciences' Short-term Investments (Quarter) stood at $778579.0 in 2017, then plummeted by 67.76% to $251000.0 in 2018, then surged by 99.6% to $501000.0 in 2019, then changed by 0.0% to $501000.0 in 2020, then changed by 0.0% to $501000.0 in 2021.
  • Its Short-term Investments was $501000.0 in Q2 2021, compared to $501000.0 in Q1 2021 and $501000.0 in Q4 2020.